Dermatology · Augusta, ME
NPI
1306046180
Since 2007
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
6 E Chestnut St
Augusta, ME, 04330
Phone (207) 623-6680
Groups this clinician bills Medicare through
Medicare paid, 2024
$42K
1,476 services
Medicare patients, 2024
343
Average age 76
Drug cost, 2024
$2.3M
1,225 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jonathan Karnes was code 17003 (destruction skin lesion), 522 times for 98 patients. In total Jonathan Karnes billed 1,476 services in 42 codes, and Medicare paid $42K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 522 | 98 | $1.37 | $713 |
| 99213 Office E&M - Established | Office | 337 | 254 | $40.10 | $14K |
| 17000 Destruction Skin Lesion | Office | 221 | 155 | $30.52 | $6,745 |
| 99214 Office E&M - Established | Office | 129 | 101 | $60.48 | $7,802 |
| 17110 Destruction Skin Lesion | Office | 95 | 79 | $46.75 | $4,442 |
| 11102 Skin Biopsy | Office | 54 | 52 | $17.49 | $945 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 17 | 17 | $11.57 | $197 |
By year: 2022 $47K for 1,577 services; 2023 $42K for 1,304 services; 2024 $42K for 1,476 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jonathan Karnes prescribed most often to Medicare patients was Clobetasol Propionate, with 195 prescriptions and refills. In total Jonathan Karnes wrote 1,225 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobetasol Propionate Generic | 195 | 224 | 108 | $13K |
| Triamcinolone Acetonide Generic | 124 | 175 | 74 | $1,421 |
| Ketoconazole Generic | 73 | 74 | 35 | $1,332 |
| Fluorouracil Generic | 56 | 56 | 51 | $4,191 |
| Doxycycline Monohydrate Generic | 55 | 103 | 25 | $2,479 |
| Dupixent Syringe Dupilumab | 46 | 46 | Under 11 | $166K |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 41 | 43 | 27 | $1,292 |
| Mycophenolate Mofetil Generic | 37 | 64 | Under 11 | $3,792 |
| Hydrocortisone Generic | 36 | 45 | 17 | $272 |
| Humira(Cf) Pen Adalimumab | 29 | 29 | Under 11 | $202K |
| Skyrizi Pen Risankizumab-Rzaa | 26 | 66 | Under 11 | $518K |
| Dupixent Pen Dupilumab | 26 | 30 | Under 11 | $114K |
| Prednisone Generic | 26 | 33 | 11 | $114 |
| Metronidazole Generic | 23 | 27 | 17 | $1,368 |
| Doxycycline Hyclate Generic | 23 | 53 | Under 11 | $1,341 |
Brand drugs: 263 claims; generic drugs: 962 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Jonathan Karnes were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.